| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |